首页>
外文期刊>International Pharmaceutical Quality
>Amgen 'Analytics of the Future' Initiative Develops MS-based 'Multi-Attribute Methodology' to Streamline Biotech Development and QC Testing
【24h】
Amgen 'Analytics of the Future' Initiative Develops MS-based 'Multi-Attribute Methodology' to Streamline Biotech Development and QC Testing
Amgen is among the major biotech companies working hard on empowering, while at the same time streamlining, their analytical toolbox at the development and quality control testing levels as the next frontier of quality by design.
展开▼